Wells Fargo’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-38
| Closed | – | – | 6125 |
|
|
2016
Q2 | $0 | Sell |
38
-9,332
| -100% | – | ﹤0.01% | 6196 |
|
|
2016
Q1 | $34K | Buy |
9,370
+1,071
| +13% | +$3.89K | ﹤0.01% | 5153 |
|
|
2015
Q4 | $83K | Sell |
8,299
-1,166
| -12% | -$11.7K | ﹤0.01% | 4866 |
|
|
2015
Q3 | $129K | Sell |
9,465
-25
| -0.3% | -$341 | ﹤0.01% | 4554 |
|
|
2015
Q2 | $180K | Buy |
9,490
+6,322
| +200% | +$120K | ﹤0.01% | 4525 |
|
|
2015
Q1 | $83K | Buy |
3,168
+185
| +6% | +$4.85K | ﹤0.01% | 4650 |
|
|
2014
Q4 | $63K | Buy |
2,983
+69
| +2% | +$1.46K | ﹤0.01% | 4750 |
|
|
2014
Q3 | $97K | Sell |
2,914
-6,189
| -68% | -$206K | ﹤0.01% | 4568 |
|
|
2014
Q2 | $291K | Sell |
9,103
-16,104
| -64% | -$515K | ﹤0.01% | 4118 |
|
|
2014
Q1 | $1.16M | Sell |
25,207
-201
| -0.8% | -$9.28K | ﹤0.01% | 3353 |
|
|
2013
Q4 | $1.8M | Sell |
25,408
-531,565
| -95% | -$37.7M | ﹤0.01% | 2996 |
|
|
2013
Q3 | $47.8M | Buy |
556,973
+452,750
| +434% | +$38.8M | 0.02% | 715 |
|
|
2013
Q2 | $6.6M | Buy |
+104,223
| New | +$6.6M | ﹤0.01% | 1889 |
|